News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
852,301 Results
Type
Article (86825)
Company Profile (704)
Press Release (764771)
Multimedia
Podcasts (143)
Webinars (19)
Section
Business (232801)
Career Advice (4132)
Deals (39758)
Drug Delivery (129)
Drug Development (91089)
Employer Resources (198)
FDA (18176)
Job Trends (17362)
News (396795)
Policy (39813)
Tag
Academia (3002)
Academic (2)
Accelerated approval (10)
Adcomms (32)
Allergies (106)
Alliances (56974)
ALS (117)
Alzheimer's disease (1556)
Antibody-drug conjugate (ADC) (187)
Approvals (18124)
Artificial intelligence (388)
Autoimmune disease (36)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (132)
Biotechnology (481)
Bladder cancer (97)
Brain cancer (40)
Breast cancer (382)
Cancer (3020)
Cardiovascular disease (243)
Career advice (3540)
Career pathing (34)
CAR-T (205)
CDC (40)
Cell therapy (564)
Cervical cancer (24)
Clinical research (74228)
Collaboration (1089)
Company closure (3)
Compensation (696)
Complete response letters (30)
COVID-19 (2900)
CRISPR (66)
C-suite (334)
Cystic fibrosis (118)
Data (3001)
Decentralized trials (2)
Denatured (50)
Depression (72)
Diabetes (375)
Diagnostics (6972)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (174)
Drug pricing (150)
Drug shortages (35)
Duchenne muscular dystrophy (130)
Earnings (97461)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131396)
Executive appointments (906)
FDA (19862)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (996)
Gene editing (146)
Generative AI (38)
Gene therapy (431)
GLP-1 (927)
Government (5252)
Grass and pollen (6)
Guidances (180)
Healthcare (20917)
Huntington's disease (32)
IgA nephropathy (43)
Immunology and inflammation (177)
Immuno-oncology (9)
Indications (40)
Infectious disease (3090)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (68)
Intellectual property (119)
Interviews (813)
IPO (17905)
IRA (55)
Job creations (5193)
Job search strategy (2863)
Kidney cancer (15)
Labor market (56)
Layoffs (587)
Leadership (26)
Legal (10135)
Liver cancer (84)
Lung cancer (426)
Lymphoma (210)
Machine learning (10)
Management (65)
Manufacturing (430)
MASH (96)
Medical device (14712)
Medtech (14717)
Mergers & acquisitions (22568)
Metabolic disorders (949)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (140)
Neuropsychiatric disorders (41)
Neuroscience (2291)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (48)
Obesity (488)
Opinion (288)
Ovarian cancer (102)
Pain (117)
Pancreatic cancer (121)
Parkinson's disease (198)
Partnered (25)
Patents (309)
Patient recruitment (159)
Peanut (55)
People (65675)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22915)
Phase II (32230)
Phase III (24267)
Pipeline (1659)
Policy (237)
Postmarket research (3552)
Preclinical (10341)
Press Release (72)
Prostate cancer (147)
Psychedelics (43)
Radiopharmaceuticals (277)
Rare diseases (513)
Real estate (7402)
Recruiting (76)
Regulatory (27108)
Reports (61)
Research institute (2664)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (9)
RSV (58)
Schizophrenia (93)
Series A (168)
Series B (113)
Service/supplier (30)
Sickle cell disease (66)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4302)
State (2)
Stomach cancer (16)
Supply chain (82)
Tariffs (64)
The Weekly (91)
Vaccines (901)
Venture capital (55)
Weight loss (328)
Women's health (50)
Worklife (20)
Date
Last 7 days (360)
Last 30 days (2184)
Last 365 days (34017)
2025 (17840)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (50507)
Australia (8875)
California (7681)
Canada (2368)
China (719)
Colorado (332)
Connecticut (344)
Delaware (202)
Europe (115862)
Florida (1139)
Georgia (262)
Hawaii (2)
Idaho (66)
Illinois (734)
India (32)
Indiana (382)
Iowa (18)
Japan (233)
Kansas (115)
Kentucky (32)
Louisiana (18)
Maine (73)
Maryland (1094)
Massachusetts (5870)
Michigan (275)
Minnesota (480)
Mississippi (3)
Missouri (100)
Montana (32)
Nebraska (26)
Nevada (82)
New Hampshire (73)
New Jersey (2155)
New Mexico (31)
New York (2160)
North Carolina (1233)
North Dakota (10)
Northern California (3302)
Ohio (249)
Oklahoma (17)
Oregon (48)
Pennsylvania (1646)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (35)
South Dakota (1)
Southern California (2830)
Tennessee (127)
Texas (1171)
United States (29043)
Utah (228)
Virginia (208)
Washington D.C. (80)
Washington State (681)
West Virginia (4)
Wisconsin (83)
There are 852,301 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
July 4, 2025
·
8 min read
Press Releases
Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025
July 4, 2025
·
1 min read
Press Releases
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
July 4, 2025
·
3 min read
Press Releases
InnoCare Announces Approval of Clinical Trial of a Novel ADC ICP-B794 in China
July 4, 2025
·
3 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 3, 2025
July 4, 2025
·
1 min read
Press Releases
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 3, 2025
July 4, 2025
·
2 min read
Press Releases
INOVIO Announces Pricing of $25 Million Public Offering
July 4, 2025
·
5 min read
Press Releases
BioAtla Presents Data from Ongoing Dose Escalation of BA3182, Dual-Conditionally Binding EpCAM x CD3 Bispecific T-cell Engager, in Patients with Treatment Refractory Metastatic Adenocarcinoma at the 2025 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress
July 4, 2025
·
9 min read
Press Releases
Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
July 4, 2025
·
5 min read
Press Releases
Johnson & Johnson submits application to the European Medicines Agency seeking indication extension of AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of adult patients with metastatic hormone-sensitive prostate cancer and HRR gene alterations
July 4, 2025
·
9 min read
1 of 85,231
Next
